Testing ADX-626 in healthy adults
This study tests a new investigational drug called ADX-626 in healthy volunteers for the first time in humans. The goal is to see how the drug is processed by the body and whether it is safe, helping to decide if it can be studied in future patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 45 years old.
- You are a man or a woman who cannot become pregnant (e.g., surgically sterile or past menopause).
- You weigh at least 110 pounds (50 kg) and have a body mass index (BMI) of 25 or less.
- You are generally healthy — no major medical conditions like high blood pressure, diabetes, heart disease, or cancer.
- You do not have a bleeding disorder and have not had serious bleeding in the past.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests the safety and how the body handles a new drug called ALXN2230 in healthy people. It helps find the right dose and checks for side effects.
This trial tests a new medicine called ADB116 in healthy people to see how safe it is and how the body processes it. The results will help decide the right dose for future studies.
This trial tests a new medicine called ADX-001 in healthy adults to see if it is safe, how the body handles it, and whether it triggers an immune response. It is an early-stage study, so it will help determine if the drug is safe enough for further testing in people with certain conditions.
This study tests a new medicine called BLX-7006 in healthy adults to see if it is safe and to learn how the body handles it. Participating could help decide if the drug should be tested in people with certain conditions later.
This trial tests a new medicine (called 627) in healthy adults to see if it is safe and how the body handles it. It may help future treatment development.
This is a first-in-human study testing a new drug called XmAb412 in healthy volunteers. It helps researchers understand how the drug works in the body and if it's safe.
Hear when a new Healthy Adult Participants trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.